With-profits bond reviews just got easier.

Advisers are not always aware of where they can find information on with-profits bonds. Essential data such as asset allocation, relative performance and bonus rates, are essential to providing sound advice, but are not easily obtained.

Clerical Medical knows that with-profits bond reviews are time consuming and complicated, so they've made them easier for you.

Help is at hand

Clerical Medical's NEW Analyser tool saves advisers time–and hassle. It helps advisers make an informed judgement as to whether their client's with-profits bond is still invested in the right fund for them.

Clerical Medical's Analyser tool is;

• FREE online tool available to ALL financial advisers,
• Designed to make with-profits bond reviews easier and quicker
• Gives advisers instant access to with-profits bond data from across the market

It also has some unique features, including

• The ability to select an alternative investment for comparison and view the impact of your specific commission arrangements
• The ability to calculate taxable gains on surrender of a bond within the tool and include this in the analysis

Click here to watch a demo of Clerical Medical's Analyser tool

Having this huge pool of information in one place will mean advisers can reduce the amount of time they normally spend obtaining this information, enabling them to give the best advice to their clients in a time efficient way.

Clerical Medical's with-profits Analyser also produces extensive reports. These are designed to help advisers meet their FSA compliance obligations. They also clearly communicate to clients the factors which have been considered and directly answer the FSA ten questions. This is increasingly important following a recent publication by the FSA.

A billion pound industry

Although new with-profits business has been relatively low, the FSA have estimated that there are millions of policies still in force, with a total asset value of around £423billion.

The FSA are concerned that these policyholders are not receiving ongoing advice on their with-profits policies, and have carried out substantial research to evidence this. An insurance sector briefing was published on 17 May 2007 called, "Quality of post-sale communications in the life sector and availability of ongoing advice to with-profits policyholders", to relay their findings to the industry. A copy of the briefing can be found on the following website - http://www.fsa.gov.uk/pubs/other/isb_quality.pdf.

The with-profits market is clearly a huge sector for advisers to target. And it's one that the FSA are suggesting advisers look at in order to treat customers fairly.

Don't delay, get reviewing today!

The with-profits market could be a business opportunity not to be missed. There are billions of pounds of investments that need regular advice, so help avoid an FSA crackdown, and help your clients in their aim to maximise their growth with Clerical Medical's with-profits Analyser.

How to access Clerical Medical's Analyser

Advisers registered for Clerical Medical's e-services can start using the tool now. Simply go to www.clericalmedical.co.uk

• Click on Adviserzone and login
• Click on Workbench to access the Analyser

Not registered for Clerical Medical's e-services?

It's easy. Just visit their website at www.clericalmedical.co.uk and select Adviser zone – this takes you through a straightforward self-registration.

Once you've registered for the Adviserzone you can get access to our full range of e-services, including our With-Profits Analyser, by sending an e-mail with 'Regpack investments' in the subject line to [email protected]

Want more information on with-profits bond reviews?

Why not get a copy of Clerical Medical's free guide to with-profits bond reviews? It gives advisers the information they need to create and implement a structured review process. Speak to your usual Clerical Medical sales contact, call 0845 128 1409 or click here to request a copy.

Coming soon

With-profits bond reviews – problems and solutions. Hear the latest from Ned Cazalet.